Role of microparticles in sepsis

Slides:



Advertisements
Similar presentations
Acute and Chronic Inflammation. W.B. Saunders Company items and derived items Copyright (c) 1999 by W.B. Saunders Company.
Advertisements

An Overview of Hemostasis
Hemostasis & Thrombosis: Platelet Disorders Beth A. Bouchard BIOC 212: Biochemistry of Human Disease Spring 2005.
Haemostasis and NovoSeven®
Coagulation (the basics) and recombinant Factor VIIa Mechanism of Action Jerrold H. Levy, MD Emory University School of Medicine and Emory Healthcare Atlanta,
Blood S-J Tsai Department of Physiology. Composition Composed of cells (erythrocytes, leukocytes, and platelets) and plasma (the liquid in which the cells.
Acute inflammation 3 By Dr. S. Homathy. This is augmented by slowing of the blood flow and increased vascular permeability, fluid leaves the vessel causing.
Hemostasis Constriction of vessel Aggregation of platelets
CHEMICAL MEDIATORS OF INFLAMMATION
Nerves Smooth muscle Endothelium Platelets White cells eg neutrophils Red cells.
Inflammation The process of inflammation initiates from tissue injury or from foreign presence its initiation is triggered by the production of: a) chemokine.
Lec.10…. Platelets (Thrombocytes) Platelets are small packages of cytoplasm that are nipped off from the cytoplasm of large mother cells in the bone.
Platelets (Thrombocytes)
Principles of Blood Coagulation
HAEMOSTASIS AND THROMBOSIS Regulation of coagulation
A. Formation of the Platelet Plug
Activation of the Hemostatic System During Cardiopulmonary Bypass
Activation of the Hemostatic System During Cardiopulmonary Bypass
2nd Year Medicine- Blood Module May 2008
Helper T cell Platelets.
Anesthes. 1997;87(3): Figure Legend:
What is haemostasis? Coagulation Fibrinolysis
Drugs Used in Coagulation Disorders
Implant of a Medical Device and the Wound Healing Process.
Review of haemostasis EACTS/ Hannes Meyer symposium 2012 Dr J Jordaan
Platelets in Atherothrombosis
by Dachuan Zhang, Chunliang Xu, Deepa Manwani, and Paul S. Frenette
Randomized trial of red cell washing for the prevention of transfusion-associated organ injury in cardiac surgery  M.J. Woźniak, N. Sullo, S. Qureshi,
Chemical Mediators Dr Shoaib Raza.
by William C. Aird Blood Volume 101(10): May 15, 2003
Figure 1 Mechanism of thrombus formation during ST-segment
Dylan Burger, Adeera Levin  Kidney International 
Physiology of the endothelium
Pharmacologic inhibition of nitric oxide synthases and cyclooxygenases enhances intimal hyperplasia in balloon-injured rat carotid arteries  Jens W Fischer,
by Julia E. Geddings, and Nigel Mackman
Coagulation and innate immune responses: can we view them separately?
Volume 55, Issue 6, Pages (December 2011)
Lipoxins: Pro-resolution lipid mediators in intestinal inflammation
Microvascular responses to sepsis: clinical significance
Immunomodulation in the critically ill
The marriage of glucose and blood vessels: It isn’t all that sweet
Oxidative stress and gene expression in sepsis
Paul A. Gurbel, and Udaya S. Tantry JCHF 2014;2:1-14
Figure 2 Initiation, amplification and propagation of coagulation
Figure 1 The coagulation system
Endothelial hyperpermeability after cardiac surgery with cardiopulmonary bypass as assessed using an in vitro bioassay for endothelial barrier function 
Histamine in the immune regulation of allergic inflammation
Nat. Rev. Nephrol. doi: /nrneph
Science for surgeons: Understanding pump thrombogenesis in continuous-flow left ventricular assist devices  Andreas R. de Biasi, MD, Keefe B. Manning,
Hydroxyethyl starch 130/0.4 decreases inflammation, neutrophil recruitment, and neutrophil extracellular trap formation  J. Rossaint, C. Berger, F. Kraft,
Peter Celec, Yoshikazu Yonemitsu  Pathophysiology 
Perioperative factor concentrate therapy
Inflammatory health effects of indoor and outdoor particulate matter
Thrombin generation and its inhibition: a review of the scientific basis and mechanism of action of anticoagulant therapies  C.P.R. Walker, D. Royston 
Editorial II British Journal of Anaesthesia
Thrombosis and Inflammatory Bowel Disease
Figure 1 Mechanisms of platelet adhesion and aggregation
Dale A Parks, Kelly A Skinner, Henry B Skinner, Sidhartha Tan 
Anti-Cytokine Therapies in Response to Systemic Infection
Figure 2 Protective functions of HDL
Section B: Science update
Immune Factors in Deep Vein Thrombosis Initiation
Systemic effects of local allergic disease
Atherosclerosis  Christopher K. Glass, Joseph L. Witztum  Cell 
HUS and atypical HUS by T. Sakari Jokiranta Blood
Trousseau's syndrome: multiple definitions and multiple mechanisms
Editorial III British Journal of Anaesthesia
HIT/HITT and alternative anticoagulation: current concepts
Multiple mechanisms in Trousseau's syndrome.
NF-κB, Inflammation, and Metabolic Disease
Presentation transcript:

Role of microparticles in sepsis V.L. Reid, N.R. Webster  British Journal of Anaesthesia  Volume 109, Issue 4, Pages 503-513 (October 2012) DOI: 10.1093/bja/aes321 Copyright © 2012 The Author(s) Terms and Conditions

Fig 1 Electron microscopy of mouse megakaryocytes demonstrating microparticle formation. Live mouse megakaryocytes forming microparticles in vitro imaged by Richardson Technology Microscopy using a ×100 objective lens. Reproduced with permission from Blood.100 British Journal of Anaesthesia 2012 109, 503-513DOI: (10.1093/bja/aes321) Copyright © 2012 The Author(s) Terms and Conditions

Fig 2 Proinflammatory potential of microparticles. Platelet-derived microparticles (PMPs) trigger a proinflammatory response through transcellular delivery of arachidonic acid (AA), metabolism to thromboxane A2 (TXA2), and COX-2 expression in endothelial cells (ECs).24 25 PMP-borne AA facilitates platelet aggregation,25 monocyte:EC interaction through ICAM-1 expression,26 and monocyte chemotaxis. The binding of PMP to leucocytes triggers leucocyte aggregation and phagocytosis.30 Microparticles derived from polymorphonuclear leucocytes (PMNL-MPs) also activate ECs with enhanced cytoadhesion and cytokine expression.27 British Journal of Anaesthesia 2012 109, 503-513DOI: (10.1093/bja/aes321) Copyright © 2012 The Author(s) Terms and Conditions

Fig 3 Procoagulant potential of microparticles. Procoagulant phospholipids (including phosphatidylserine) are exposed on the exoplasmic surface of platelet-derived microparticles (PMPs) during microparticle (MP) formation. Phosphatidylserine enhances factor VaXa (FVaXa)19 and tissue factor (TF) activity. Through processes partly dependent on the GPIIb/IIIa complex, PMPs adhere to the subendothelial matrix and coaggregate with platelets.36 PMPs also express coagulation factor binding sites for factor IXa, Xa, and VIII (FIXa, FVa, and FVIII, respectively).37 Endothelial-derived MPs (EMPs) potentiate platelet aggregation and thrombus formation by expression of ultra large von Willebrand factor (ULvWF) antigen40 41 and coagulation factor binding sites.42 MPs including PMPs, EMPs, and leucocyte-derived MPs (PMNL-MPs) constitute a circulating storage pool of blood-borne TF,11 where leucocytes carrying TF are concentrated to sites of vascular injury via interaction of platelet P-selectin and PSGL-1 expressed on LMPs.39 British Journal of Anaesthesia 2012 109, 503-513DOI: (10.1093/bja/aes321) Copyright © 2012 The Author(s) Terms and Conditions

Fig 4 Microparticles and endothelial (dys)function. Through transcellular delivery of arachidonic acid (AA) and endothelial cell (EC) metabolism to thromboxane A2 (TXA2), platelet-derived microparticles (PMPs) induces vascular hyperreactivity on vascular smooth muscle cells (VSMC). In vitro endothelial-derived microparticles (EMPs) increase superoxide anion production and reduce nitric oxide (NO) levels in ECs.54 Microparticles (MPs) derived from T-lymphocytes (LymMPs) reduce NOS3 expression in conductance and resistance vessels, reducing NO production.55 LymMPs also induce vascular hyporeactivity through reduced NOS2 and COX-2 expression in VSMC.56 British Journal of Anaesthesia 2012 109, 503-513DOI: (10.1093/bja/aes321) Copyright © 2012 The Author(s) Terms and Conditions

Fig 5 Role of microparticles in sepsis. Elevated levels of platelet, endothelial cell (EC), and polymorphonuclear leucocyte (PMNL)-derived microparticles (MPs) are seen in sepsis.20 Platelet-derive MPs (PMPs) and PMNL-MPs are procoagulant with thrombin generation occurring via a tissue factor (TF)/factor VIIa (FVIIa)-dependent pathway.20 PMNL-MPs demonstrate increased expression of adhesion molecules82 and EC-derived MP (EMPs) adhere to leucocytes and increase phagocytic activity.83 MPs isolated from septic rats induce vascular hyporeactivity via NF-кB activation, enhanced expression of NOS2, and increased oxidative stress.86 Increased production of thromboxane A2 (TXA2) may compensate for vascular hyporeactivity associated with hypotension in septic shock.87 88 Through differential effect on target tissues, microparticles induce expression of enzyme systems related to inflammation and nitrative and oxidative stress.88 95 British Journal of Anaesthesia 2012 109, 503-513DOI: (10.1093/bja/aes321) Copyright © 2012 The Author(s) Terms and Conditions